ロード中...
TNFR2 is required for RIP1-dependent cell death in human leukemia
Despite major advances in the treatment of patients with acute lymphoblastic leukemia in the last decades, refractory and/or relapsed disease remains a clinical challenge, and relapsed leukemia patients have an exceedingly dismal prognosis. Dysregulation of apoptotic cell death pathways is a leading...
保存先:
| 出版年: | Blood Adv |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7556136/ https://ncbi.nlm.nih.gov/pubmed/33027529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000796 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|